Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience

BACKGROUND: Cure rates for chronic hepatitis C have improved dramatically with direct-acting antivirals (DAAs), but treatment barriers remain. We aimed to compare treatment initiation rates and barriers across both interferon-based and DAA-based eras. METHODS: We conducted a retrospective cohort stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Peter, Vutien, Philip, Hoang, Joseph, Trinh, Sam, Le, An, Yasukawa, Lee Ann, Weber, Susan, Henry, Linda, Nguyen, Mindie H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759739/
https://www.ncbi.nlm.nih.gov/pubmed/29333275
http://dx.doi.org/10.1136/bmjgast-2017-000181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759739/
https://www.ncbi.nlm.nih.gov/pubmed/29333275
http://dx.doi.org/10.1136/bmjgast-2017-000181

Ejemplares similares